Insect Biotechnology Market Size is USD 1.19 Billion in 2026

The global insect biotechnology market is projected to grow from USD 1.07 billion in 2025 to approximately USD 3.15 billion by 2035, expanding at a CAGR of 11.40%, driven by rising demand for sustainable protein, bio-based products, and innovative agricultural solutions.

Insect Biotechnology Market Statical Scope

Market Overview

The transitioning agricultural innovation and excess pharmaceutical and medical use mark the market’s rapid success. The market is well known for its molecular methods/techniques, a few synthetic biology (to insect components and cells), and its famous genetic mechanism. The market evolves in various sectors, either in the form of services or as a responsible developer of eco-conscious products. The market is a solution to many medical, industrial, and agricultural challenges.

Regional Insights

• North America: The biomanufacturing platforms and modernised pest management services are revolutionising the regional market’s strength.
• Europe: The highest investment volume and regulatory interest encourage and pave the way for innovation and sustainability to advance with greater confidence, earning regional profits.
• Asia Pacific: The region, backed by regulatory and technological innovation, is a boon to the markets' new endeavours and initiatives.
• Latin America: The giant players and institutional support are introducing awareness, aligning with the regulatory standards, and considering registration frameworks to earn legal and worthy, undisturbed profit for market growth.
• Middle East & Africa: The accelerating demand for sustainable protein sources/supplements and involvement of IPM practices is elevating the regional market growth.

Insect Biotechnology Market Share, By Region, 2025 (%)

• North America (34%) — Region characterized by advanced insect farming infrastructure, regulatory support, and growing demand for sustainable protein alternatives.
• Europe (27%) — Market driven by strong sustainability policies, circular economy initiatives, and increasing adoption of insect-based feed solutions.
• Asia Pacific (25%) — Rapidly expanding region supported by rising protein demand, large livestock production base, and growing biotech investments.
• LAMEA (14%) — Emerging market region with gradual adoption of insect biotechnology, primarily driven by agricultural and feed sector development.

Segmental Insights

By Application

• Animal Feed: This segment is experiencing a shift with its rich and high-protein alternative delivery, and also promotes sustainable delivery to existing fishmeal and soybean.
• Medical: This medical segment is emerging in pharmacology, biomanufacturing platforms, precision diagnostics, and modern clinical therapies.

Insect Biotechnology Market Share, By Application, 2025 (%)

• Animal Feed (62%) — Application segment focused on utilizing insect-derived proteins and nutrients as sustainable ingredients in livestock, aquaculture, and pet feed formulations.
• Medical (38%) — Segment involving the use of insect-based biomaterials, bioactive compounds, and derivatives for pharmaceutical, therapeutic, and biomedical applications.

By Type

• Extracted Oil: This segment is a famous product, proving its potential in pharmaceuticals, biofuels, and food. The modern extraction technologies elevate the segmental growth, harnessing the market’s consistent progress.
• Extracted Powder: The extracted powder product is an additional promotion to the nutritional growth, along with its modernised extraction methods. It also captures the functionality potential of insects to fit in various applications.

Insect Biotechnology Market Share, By Type, 2025 (%)

• Extracted Oil (55%) — Product type consisting of lipid-rich oil derived from insect biomass, primarily used in feed, nutraceutical, and industrial formulations.
• Extracted Powder (45%) — Protein-rich powdered insect derivative processed for incorporation into feed, food, and specialized biotechnology applications.